Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5aad79177a135e936f42ee9f7148c8ea http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed17f66ab9461b49d0ad6c1088d8747b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ce03f89c6d9f6f5ef62664aebdae462b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3841fc782c3fa6a0bb14960b6ebc2685 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18472f143d5f75bd40eac8cbf7d50de2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b869e02ac2f2e329e0ef209fdff057f4 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70571 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-043 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 |
filingDate |
2006-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2012-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f23fadabc9ce510eb57c69c710c58b9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f144a81aa386ee8f152c1a0d68cc59ff http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6d504050c7b17358a18681f04b5c61e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6932887e5c7572a192b0e21a157b13bc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40bc9e5848414f2afb42c5ead919509e |
publicationDate |
2012-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8318657-B2 |
titleOfInvention |
Methods and compositions for preventing and/or treating pancreatitis |
abstract |
The present invention relates to a method of preventing and/or treating pancreatitis in a subject, the method including administering to the subject a therapeutically effective amount of a Galanin antagonist and/or a Galanin receptor antagonist. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10898592-B2 |
priorityDate |
2005-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |